Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 March 2025 | Story Litha Banjatwa | Photo Supplied
Fiesta winners 2025
Ons wag vir Godot shines at the 2025 kykNET Fiësta Awards, winning three major accolades and cementing UFS’s reputation for world-class theatre excellence.

Ons wag vir Godot, a groundbreaking stage production from the University of the Free State (UFS) Department of Drama and Theatre Arts, was one of the biggest winners at the 2025 kykNET Fiësta Awards, which celebrate the best of Afrikaans theatre.

The awards ceremony was held at the Kirstenbosch National Botanical Garden in Cape Town on 27 February 2025.

Ons wag vir Godot, an Afrikaans translation of Irish writer Samuel Beckett’s celebrated 1953 play Waiting for Godot, won three of its four nominations: Best Director for Dion van Niekerk, Best Translation for Naomi Morgan, and Best Supporting Actor for Gerben Kamper. This haul positioned Ons wag vir Godot as the second biggest winner of the evening, and marked an unprecedented achievement for a Free State production at the Fiësta Awards.

This success builds upon the play’s earlier triumphs at the Free State Arts Festival, where it received accolades for Best Director, Best Translation, Best Supporting Actor (Peter Taljaard), and Best Ensemble.

Director Dion van Niekerk said what set Ons wag vir Godot apart was its unique origin: it is the first Afrikaans translation of Beckett's masterpiece directly from the French original. Securing the translation rights was no small feat, requiring a special appeal to the notoriously selective Samuel Beckett Estate.

“The production’s greatest challenge lay in making the play accessible to a South African audience,” Van Niekerk said. “We aimed to find a stage language with visual imagery that would situate the play within a recognisable South African context."

This was achieved through Naomi Morgan’s “immaculate translation work, which captured the existential concerns of the play with precisely the right Afrikaans vocabulary and turns of phrase”. The production team further grounded the play in South African reality through the creation of characters, setting, and costuming that evoked the stark beauty of the Karoo landscape.

The success of Ons wag vir Godot has profound implications for the UFS Department of Drama and Theatre Arts. It firmly establishes the department among the nation’s leading drama institutions, showcasing its ability to contribute high-quality, meaningful work to the South African artistic landscape. “This production highlights the importance of performing translated classics,” Van Niekerk said. “Works like Waiting for Godot are part of the canon of great international theatrical works. South Africa was banned from producing this play during apartheid, and it has been rarely seen since, predominantly in English.” This production, therefore, offers Afrikaans-speaking South Africans and others a unique opportunity to engage with Beckett’s timeless work.

The impact of this success extends to the department’s students. Sibabalwe Jokani, a student cast member, shared in the nominations for Best Ensemble at both the Free State Festival and Fiësta Awards. Jokani said the play’s success has inspired the student body and reaffirmed the department’s commitment to high standards and industry access.

When asked about the future of Afrikaans theatre, Van Niekerk said, “This production will hopefully inspire others to continue to reconsider the value that great theatrical works that have been created in other languages might have in a contemporary Afrikaans context.”

News Archive

Conference: Expanded ARV treatment
2005-03-02

VENUE: University of the Free State, Bloemfontein, South Africa
DATE: 30 March 2005 - 1 April 2005

  • ARV Programme as on 24Feb Download Word document
     
  • Programme Special events Download Word document


    Official web site www.fshealth.gov.za/subsites/arvc

     


    Rationale for the Conference
    At the time of the planned Conference, much ground would have been covered, both in the Free State and in South Africa, in respect of the expanded public sector ARV treatment programme in respect of research, experiences in practice, training of staff, treatment of patients, lessons learned, successes and failures, etc. The time would then be quite opportune to share these in a systematic manner with other provinces and countries, as well as with the large variety of stakeholders and role players in the ARV and related domains, be they academics and researchers, policy makers and service/facility managers, the variety of caregivers, and the community organisations and affected patients.

The Conference and current research
The proposed Conference is, firstly, directly linked to the current research on the public sector roll-out of ARV treatment in the Free State conducted by several research institutions (e.g. CIET, CHSR&D, UCT Lung Institute). Secondly, the Conference could and would serve as a forum for other research groups in the country and further a field to report and share knowledge and experiences on ARV treatment and related initiatives. Lastly, the Conference will stage a golden opportunity for researchers and scientists, on the one hand, and policy makers, managers, and caregivers (as knowledge users), on the other hand, to engage in cross-disciplinary discourse on this mutual and topical theme.

Theme of Conference
Expanded ARV treatment in the Free State: sharing experiences

Focus
The focus is primarily on public sector ARV treatment in the Free State, but also initiatives/activities/perspectives of relevance to the Free State elsewhere in the country at large and further a field, as well as relevant ARV initiatives in the public, private, NGO and FBO sectors. Bear in mind, however, that ARV treatment is but part of a much more comprehensive approach to HIV and AIDS. The Conference will, therefore, not narrowly focus on the ARV treatment programme only. The broader context, other relevant dimensions, and a comprehensive approach to the challenges of HIV, AIDS and TB are of equal importance.

The purpose of the Conference
Enhance meaningful exchange, mutual understanding and collaboration among researchers, scientists, policy makers, managers and practitioners in the field of ARV treatment and related fields.

Share experiences in the various spheres of ARV treatment and related spheres (policy, management, practice, research, training, public-private-civil society sectors).

Record, reflect and report on the establishment of the ARV treatment programme in the Free State, and in within the context of the comprehensive HIV/AIDS programme.

Disseminate important research results on ARV treatment and related themes to health policy makers, managers, practitioners, communities and to the research community.

Stimulate discourse among various disciplines and various stakeholders/role players involved in ARV treatment and related programmes.

Sensitise and acquaint researchers to the requirements of policy makers, managers and practitioners in respect of ARV treatment and related fields.

Facilitate the implementation of research results in ARV treatment policy, programmes and practice.

Dissemination of Conference-related information
Information generated during the Conference could feed into policy, management and practice of ARV treatment, the training accompanying such programme, and the existing body of knowledge. After the Conference the information will be disseminated via the Internet and by scientific and popular publications.

Date and duration
Set for 30 & 31 March & 1 April 2005; to commence at 09:00 on the first day (30 March) and to end at 16:30 (1 April) the third day.

Format and scope of Conference
Alternating plenary, parallel sessions and debates focused on topical issues and interest groups. The Conference will strive to be maximally interactive and participative.

Themes and topics to cover:

  • Policy, management and health services/practice (various levels and contexts – clinical treatment, information, IT systems, pharmacy, laboratories, nutrition)
     
  • Research covering all relevant disciplines and diverse dimensions of ARV treatment and related themes
  • Training and evaluation of training
  • Patients, communities and civil society organisations
  • Public, private, NGO, FBO initiatives and partnerships

Emphasis will be on the Free State, however, with of significant involvement from other provinces, SADC countries, and countries further a field. The thrust will be to export lessons and experiences from the Free State, but also to import lessons and experiences from other provinces, countries and sectors.

Presenters
Key presenters from the Free State, other provinces, South Africa, from the private, FBO and NGO sectors, and from several other countries

Delegates
About half of the delegates will be Free State stakeholders and role players (all levels and all contexts). The other half will be role players and stakeholders in the ARV and related fields from other provinces, the national level, and other countries, as well as from the private, public and non-governmental sectors.

Focused workshops
Provision will be made for half-a-day or one-day workshop initiatives on the third day (1 April 2005).

Enquiries
For more information please contact:

Prof Dingie van Rensburg
Centre for Health Systems Research & Development
University of the Free State
PO Box 339
Bloenfontein
SOUTH AFRICA
9300

Contact:
Carin van Vuuren
Conference Organiser
Centre for Health Systems Research & Development
University of the Free State
P.O.Box 339
Bloemfontein
South Africa
9300
Tel +27 (0) 51 401 2181
Fax +27 (0) 51 4480370
Cell 0832932890
e-mail: arvconference.hum@mail.uovs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept